SCHEMBL17075211

SCHEMBL17075211

CC(C(N)=O)N1CCC(C(=O)O)c2ccccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 3/20 0.38
KMT2A Q03164 2/20 0.36
HTR6 P50406 1/20 0.35
ALOX15 P16050 1/20 0.35
CNR2 P34972 1/20 0.35
CDC42 P60953 3/20 0.35
RAC1 P63000 3/20 0.35
PTGS1 P23219 2/20 0.35
PTGS2 P35354 2/20 0.35
NPC1 O15118 1/20 0.35
CHRM3 P20309 1/20 0.35
OPRM1 P35372 1/20 0.35
RAB9A P51151 1/20 0.35
PAK1 Q13153 1/20 0.35
LMNA P02545 1/20 0.34
HTT P42858 1/20 0.34
PSEN1 P49768 1/20 0.34
PSEN2 P49810 1/20 0.34
APH1B Q8WW43 1/20 0.34
NCSTN Q92542 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17075191 0.81 NOTUM (0.35) NOTUMKMT2ACNR2CHRM3LMNA
SCHEMBL12019284 0.81 NOTUM (0.40) NOTUMKMT2AALOX15NPC1OPRM1
SCHEMBL17075198 0.79 DPP4 (0.35) NOTUMKMT2ACNR2LMNAHTT
SCHEMBL28280937 0.75 NOTUM (0.43) NOTUMKMT2AHTR6CDC42RAC1
SCHEMBL30899464 0.75 KDM4C (0.44) NOTUMHTR6CNR2CDC42RAC1
SCHEMBL16250257 0.75 KDM4C (0.44) NOTUMHTR6CNR2CDC42RAC1
SCHEMBL15523890 0.72 GPBAR1 (0.43) OPRM1
SCHEMBL7353475 0.72 CHRM2 (0.40) KMT2ACHRM3
SCHEMBL28280809 0.72 NOTUM (0.41) NOTUMKMT2AHTR6CDC42RAC1
SCHEMBL11984354 0.71 CACNA1G (0.43) NOTUMKMT2ACDC42RAC1PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3116874-B1 HEXAHYDRODIAZEPINOQUINOLINES CARRYING A SUBSTITUTED ALKYL RADICAL ABBVIE DEUTSCHLAND (DE) 2018-02-28 EP disclosed
US-20170112851-A1 HEXAHYDRODIAZEPINOQUINOLINES CARRYING A SUBSTITUTED ALKYL RADICAL AbbVie Deutschland GmbH & Co. KG (DE) 2017-04-27 US disclosed
US-9540376-B2 Hexahydrodiazepinoquinolines carrying a substituted alkyl radical AbbVie Deutschland GmbH & Co. KG (DE) 2017-01-10 US disclosed
US-20150259346-A1 HEXAHYDRODIAZEPINOQUINOLINES CARRYING A SUBSTITUTED ALKYL RADICAL AbbVie Deutschland GmbH & Co. KG (DE) 2015-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170112851-A1 HEXAHYDRODIAZEPINOQUINOLINES CARRYING A SUBSTITUTED ALKYL RADICAL HTR2C, HTR2A, HTR3C NOTUM 3126/4885KMT2A 1332/4885HTR6 18/4885
US-20150259346-A1 HEXAHYDRODIAZEPINOQUINOLINES CARRYING A SUBSTITUTED ALKYL RADICAL HTR2C, HTR2A, HTR3C NOTUM 3126/4885KMT2A 1332/4885HTR6 18/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.